Study guide
11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy)
AACVPR CCRP Certified Cardiac Rehab Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Cardiac Rehabilitation Foundations
1.1 AACVPR CCRP Credential, Exam Specifications & Core Competencies 1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models 1.3 Interdisciplinary Team Roles, Clinical Scope of Practice & Safety
2 Chapter 2: Cardiovascular Anatomy, Physiology & Pathology
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics 2.2 Atherosclerosis Pathogenesis, Acute Coronary Syndromes (ACS) & Revascularization 2.3 Heart Failure (HFrEF/HFpEF), Cardiomyopathies & Valvular Heart Disease 2.4 Electrical Interventions: Cardioversion, Catheter Ablation & Post-Procedure Rehabilitation
3 Chapter 3: Diagnostic Evaluation, ECG & Clinical Testing
3.1 Baseline Clinical Assessment & AACVPR Risk Stratification 3.2 12-Lead ECG Interpretation: Ischemia, Transmural Infarction & Conduction 3.3 Cardiac Arrhythmias, Conduction Blocks & Device Rhythms (Pacemakers/ICDs) 3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria
4 Chapter 4: Patient-Centered Assessment: Education, Equity & Social Context
4.1 Learning Readiness: Health Literacy, Learning Styles & Communication Barriers 4.2 Social Determinants of Health, Culture & Spirituality in Cardiac Rehab 4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes 4.4 Substance Use Screening: Alcohol, Cannabis, Stimulants & Cardiac Risk
5 Chapter 5: Exercise Prescription & Aerobic Conditioning
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation 5.2 Exercise Progression, Environmental Factors & Telemetry Monitoring Guidelines 5.3 High-Intensity Interval Training (HIIT) vs Moderate Continuous Training (MICT) 5.4 Home Exercise Program Design, Prescription & Independent Progression
6 Chapter 6: Exercise Physiology, Monitoring & Session Design
6.1 Health-Related Physical Fitness Components & Functional Capacity Testing 6.2 Acute Cardiovascular Responses to Aerobic Exercise: METs, Rate Pressure Product & VO₂ 6.3 Chronic Training Adaptations in Cardiac Patients 6.4 Structuring the Exercise Session: Warm-Up, Conditioning & Cool-Down 6.5 ECG Telemetry Setup: Skin Preparation, Electrode Placement & Artifact Troubleshooting 6.6 Pulse Oximetry, Exertional Desaturation & Supplemental Oxygen Titration
7 Chapter 7: Resistance, Flexibility & Exercise Safety
7.1 Resistance Training Guidelines, Hemodynamics & Sternal Precautions 7.2 Flexibility, Neuromotor Training & Special CR Populations 7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
8 Chapter 8: Physical Activity Counseling & Behavior Change
8.1 Physical Activity Guidelines, Sedentary Physiology & NEAT 8.2 Behavioral Change Theories: Transtheoretical Model & Social Cognitive Theory 8.3 Motivational Interviewing Principles & Resolving Ambivalence 8.4 SMART Goal Setting, Activity Tracking & Relapse Prevention
9 Chapter 9: Physical Activity Assessment & Real-World Activity Counseling
9.1 Physical Activity vs Exercise: Assessment Instruments, Logs & Wearables 9.2 Metabolic Requirements of Daily Life: Occupational, Recreational & Sexual Activity 9.3 Environmental & Situational Risk: Heat, Cold, Altitude, Air Quality & High-Risk Activities 9.4 Upper- vs Lower-Body Physiologic Demands & Modality Selection
10 Chapter 10: Hypertension & Blood Pressure Regulation
10.1 2017 ACC/AHA Hypertension Classification & Cardiovascular Risk 10.2 Antihypertensive Pharmacology & Exercise Hemodynamics 10.3 Exertional Blood Pressure Dynamics, Exertional Hypotension & Crisis 10.4 Home Blood Pressure Monitoring, Sodium Restriction & Lifestyle Interventions 10.5 Blood Pressure Measurement Technique, Device Validation & Renal Protection
11 Chapter 11: Diabetes Mellitus & Metabolic Regulation
11.1 Diabetes Pathophysiology, Diagnostic Criteria & Glycemic Targets 11.2 Antidiabetic Pharmacotherapy (Insulin, Sulfonylureas, SGLT2i, GLP-1 RA) 11.3 Exercise-Induced Hypoglycemia Management (Rule of 15) & Hyperglycemia 11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy) 11.5 Blood Glucose Self-Monitoring, CGM Interpretation & Peri-Exercise Testing 11.6 Diabetic Foot Care, Skin Integrity & Footwear Assessment
12 Chapter 12: Blood Lipid Management & Atherosclerosis Prevention
12.1 Lipid Metabolism, Atherogenic Lipoproteins & Advanced Lipid Testing 12.2 Statin Therapy, Dosing Intensity & Secondary Prevention Targets 12.3 Non-Statin Pharmacotherapies & Statin-Associated Muscle Symptoms (SAMS)
13 Chapter 13: Medical Nutrition Therapy & Dietary Patterns
13.1 Nutritional Assessment & Macronutrient Guidelines in Cardiovascular Disease 13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based 13.3 Dietary Lipids, Sodium, Soluble Fiber & Plant Stanols/Sterols 13.4 Clinical Scope: CR Professional Counseling Boundaries vs RD/RDN Referral
14 Chapter 14: Body Composition & Weight Management
14.1 Anthropometric Assessment: BMI, Waist Circumference & Obesity Paradox 14.2 Behavioral Weight Management, Energy Balance & Caloric Deficits 14.3 Anti-Obesity Pharmacotherapy (GLP-1/GIP) & Bariatric Surgery Considerations
15 Chapter 15: Tobacco Cessation Interventions
15.1 Cardiovascular Pathophysiology of Tobacco, Nicotine & Secondhand Smoke 15.2 Clinical Cessation Frameworks: The 5 A's & 5 R's Models 15.3 Pharmacotherapy for Nicotine Dependence: NRT, Varenicline & Bupropion 15.4 Behavioral Counseling, Coping Strategies & Relapse Prevention
16 Chapter 16: Psychosocial Health, Screening & Behavioral Support
16.1 Psychosocial Risk Factors & Prognostic Impact in Heart Disease 16.2 Validated Screening Instruments: PHQ-9, GAD-7 & Administration 16.3 Evidence-Based Interventions: Stress Management, CBT Principles & Social Support 16.4 Crisis Protocols, Suicidal Ideation & Mental Health Referral Pathways 16.5 Psychotropic Pharmacology & Cardiac Safety 16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management
17 Chapter 17: Regulatory Compliance, Documentation & Program Outcomes
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision 17.2 Individualized Treatment Plan (ITP) Components, 30-Day Updates & Goals 17.3 AACVPR Outcome Domains & Program Certification Performance Measures 17.4 Program Certification, Quality Improvement & Medical Emergency Preparedness
11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy)
Key Takeaways Explain This Topic AI
Cardiovascular Autonomic Neuropathy (CAN) causes resting tachycardia (>100 bpm), chronotropic incompetence, severe orthostatic hypotension (drop >=20 mmHg systolic or >=10 mmHg diastolic upon standing), and silent myocardial ischemia, necessitating continuous telemetry and the exclusive use of Borg RPE for intensity monitoring.
Because chronotropic incompetence and autonomic denervation render heart rate-based training formulas (Karvonen HRR, %HRmax) invalid in patients with CAN, the Borg Rating of Perceived Exertion (RPE 11–14 on the 6–20 scale) serves as the mandatory primary metric for exercise titration.
Diabetic Peripheral Neuropathy (DPN) causes loss of protective sensation (LOPS) detectable via 10g Semmes-Weinstein monofilament testing, requiring mandatory pre- and post-exercise visual foot inspections, seamless moisture-wicking footwear, and substitution of high-impact treadmill running with low-impact or non-weight-bearing modalities (recumbent stepper, cycle ergometer).
Active proliferative diabetic retinopathy (PDR) or severe non-proliferative retinopathy contraindicates vigorous aerobic exercise, heavy resistance training (>80% 1RM), Valsalva straining, and head-down or inverted postures due to high risk of vitreous hemorrhage and retinal detachment.
Diabetic nephropathy is staged by urinary albumin-to-creatinine ratio (microalbuminuria 30–300 mg/g; macroalbuminuria >300 mg/g); while exercise induces transient post-exertional proteinuria, it does not hasten renal decline, provided exertional blood pressure spikes (>220 mmHg systolic) and dehydration are avoided.
Last updated: September 2026
11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy)
Note
Clinical Vulnerability & Exercise Modification : Chronic diabetic complications—including cardiovascular autonomic neuropathy (CAN), distal symmetrical peripheral neuropathy (DPN), diabetic retinopathy, and diabetic nephropathy—fundamentally alter human exercise physiology. In cardiac rehabilitation, these conditions impair normal hemodynamic reflexes, eliminate ischemic pain signals, alter thermoregulation, and create severe skin ulceration risks. Safe exercise prescription demands tailored clinical adaptations rather than generic fitness formulas.
Secondary prevention professionals must identify diabetic target-organ complications during baseline clinical assessment. Appropriate screening, modality modification, and hemodynamic monitoring prevent catastrophic adverse events, including unheralded myocardial infarction, severe orthostatic collapse, non-healing neuropathic foot ulcers, and vitreous retinal hemorrhage.
Cardiovascular Autonomic Neuropathy (CAN)
Cardiovascular Autonomic Neuropathy is an insidious, frequently underdiagnosed complication affecting approximately 20% to 40% of diabetic patients with established cardiovascular disease. It represents damage to the autonomic nerve fibers innervating the heart and systemic vascular beds.
Pathophysiology & Nerve Fiber Degeneration
Mechanisms : Chronic neurovascular ischemia of the vasa nervorum, oxidative stress, and polyol pathway sorbitol accumulation damage both parasympathetic and sympathetic axons.
Vagal Vulnerability : The vagus nerve (cranial nerve X) is the longest autonomic nerve in the body, accounting for ~75% of all parasympathetic fibers. Because diabetic neuropathy is length-dependent, vagal parasympathetic fibers suffer early damage, leading to parasympathetic denervation . Later in the disease course, sympathetic nerve fibers degenerate, leading to complete cardiac autonomic denervation .
Cardinal Clinical Manifestations of CAN
Resting Tachycardia : Early loss of parasympathetic vagal inhibition removes the normal inhibitory "brake" on the sinoatrial (SA) node, allowing uninhibited sympathetic tone to dominate. Patients exhibit resting heart rates characteristically fixed between 90 and 110 bpm 90\text{ and }110\text{ bpm} 90 and 110 bpm , accompanied by a profound loss of normal Heart Rate Variability (HRV).
Chronotropic Incompetence : The heart fails to accelerate heart rate appropriately in response to exertional physical demand. Patients are unable to achieve ≥ 85 % \ge 85\% ≥ 85% of their age-predicted maximal heart rate or exhibit a blunted Heart Rate Reserve index ( < 0.80 < 0.80 < 0.80 ).
Severe Orthostatic Hypotension : Efferent sympathetic vasomotor denervation impairs reflexive arteriolar vasoconstriction and venoconstriction in the splanchnic and lower-extremity vascular beds upon assuming an upright posture. Defined clinically as a sustained drop in systolic blood pressure ≥ 20 mmHg \ge 20\text{ mmHg} ≥ 20 mmHg or diastolic blood pressure ≥ 10 mmHg \ge 10\text{ mmHg} ≥ 10 mmHg within 3 minutes of standing from a supine or seated position. Critically, because the SA node is denervated, this profound blood pressure drop occurs without a compensatory reflex tachycardia , leading to sudden cerebral hypoperfusion, dizziness, presyncope, or falls.
Silent Myocardial Ischemia & Painless Infarction : Afferent sensory sympathetic fibers traversing the cardiac plexus convey anginal pain signals to the dorsal horn of the spinal cord ( T 1 – T 5 T_1\text{--}T_5 T 1 – T 5 ). Autonomic denervation eliminates angina pectoris perception. Patients experience completely silent myocardial ischemia or present with subtle "anginal equivalents": sudden unheralded diaphoresis, acute dyspnea, nausea, profound unexplained fatigue, or acute transient telemetry arrhythmias (frequent PVCs, couplets, ST-segment depression).
Impaired Thermoregulation : Sudomotor denervation leads to peripheral anhidrosis (absence of sweating on extremities) with compensatory facial and trunk hyperhidrosis. Impaired cutaneous vasodilation severely diminishes evaporative heat dissipation, placing patients at high risk for exertional hyperthermia and heat exhaustion during warm-environment training.
Mandatory Exercise Adaptations for CAN
Target Heart Rate Invalidation : Because resting heart rate is elevated and exertional acceleration is blunted, standard heart rate-based exercise prescription methods—such as the Karvonen Heart Rate Reserve formula or percentage of maximal heart rate ( % H R m a x \%HR_{max} % H R ma x )—are clinically invalid, misleading, and potentially hazardous .
Mandatory Use of Borg Rating of Perceived Exertion (RPE) : Clinicians must rely primarily on the Borg 6 to 20 RPE scale , prescribing exercise intensity within the moderate-intensity range of 11 to 14 ("fairly light" to "somewhat hard") .
Extended Warm-Up and Cool-Down : Mandate prolonged 10 – 15 minute 10\text{--}15\text{ minute} 10 – 15 minute active warm-up and cool-down periods at very light intensity ( < 30 % HRR < 30\%\text{ HRR} < 30% HRR or RPE ≤ 10 \le 10 ≤ 10 ) to permit sluggish systemic vascular autoregulation and avoid acute post-exercise venous pooling and syncope.
Continuous Telemetry Monitoring : Phase II patients with documented or suspected CAN must undergo continuous ECG telemetry during all training sessions to screen for asymptomatic ST-segment depression and ventricular ectopy.
Diabetic Peripheral Neuropathy (DPN) & Foot Protection
Diabetic Peripheral Neuropathy is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy affecting more than 50% of older diabetic adults.
Clinical Assessment & Loss of Protective Sensation (LOPS)
The 10-Gram Semmes-Weinstein Monofilament Test : The definitive clinical instrument for detecting Loss of Protective Sensation (LOPS) . The nylon monofilament is applied perpendicular to the skin surface until it buckles (delivering exactly 10 grams 10\text{ grams} 10 grams of linear force). Standardized testing evaluates 4 primary plantar sites per foot: the plantar surface of the great toe (hallux) , and the 1st, 3rd, and 5th metatarsal heads .
Diagnostic Interpretation : Inability of the patient to perceive the touch of the buckling monofilament at ≥ 1 \ge 1 ≥ 1 site confirms LOPS, identifying an insensate foot at high risk for neuropathic ulceration.
Additional Sensory Testing : Assessment of vibratory perception using a 128-Hz tuning fork at the dorsum of the great toe interphalangeal joint, pinprick sensation, and bilateral Achilles deep tendon reflexes.
Pathophysiological Consequences in Exercise
Patients with LOPS cannot perceive repetitive friction, shear stress, blister formation, or foreign objects within athletic footwear. Unchecked repetitive mechanical trauma leads to skin breakdown, deep subcutaneous tissue necrosis, chronic non-healing ulcers, osteomyelitis, and lower-extremity amputation. In advanced cases, motor neuropathy causes intrinsic foot muscle atrophy, resulting in toe clawing, prominent metatarsal heads, and joint subluxation ( Charcot neuroarthropathy / "rocker-bottom" foot).
Exercise Adaptations & Clinical Footwear Rules
Mandatory Visual Foot Inspections : Clinicians and patients must perform a thorough visual inspection of bilateral feet before and immediately after every exercise session . Inspect for erythema, localized warmth, edema, calluses, blisters, abrasions, skin fissures, interdigital maceration, or nail trauma.
Therapeutic Footwear Guidelines :
Athletic shoes must possess a wide, deep toe box , seamless interior lining, rigid rocker-bottom soles, and adequate shock-absorbing viscoelastic orthotic insoles.
Shoes must be properly fitted by a certified pedorthist or podiatrist and broken in gradually (worn for < 1 hour/day < 1\text{ hour/day} < 1 hour/day initially).
Socks : Patients must wear clean, dry, seamless, moisture-wicking athletic socks constructed of synthetic acrylic or polyester blends . 100% cotton socks must be strictly avoided because cotton traps sweat, becomes wet and abrasive, and promotes blister formation and fungal infections.
Strict Prohibition of Barefoot Exercise : Walking barefoot or exercising in thin-soled open footwear is completely prohibited.
Exercise Modality Modifications :
Patients with LOPS, active plantar ulcers, or Charcot foot deformity must avoid high-impact, weight-bearing activities (e.g., treadmill running, outdoor jogging, high-step aerobics, or rope jumping).
Shift to low-impact or non-weight-bearing modalities : seated recumbent stepper (NuStep) , stationary upright or recumbent cycle ergometer , and upper-body arm ergometer .
Aquatic therapy and swimming provide non-weight-bearing conditioning but are strictly contraindicated if open skin ulcers, incisions, or fungal infections are present .
Diabetic Retinopathy: Exercise Safety & Pressure Limits
Diabetic retinopathy is a microvascular complication characterized by retinal capillary microaneurysms, vascular hyperpermeability, ischemia, and neovascularization.
Non-Proliferative (NPDR) vs. Proliferative Diabetic Retinopathy (PDR)
NPDR : Characterized by microaneurysms, dot-and-blot hemorrhages, and cotton-wool spots (microinfarcts). Exercise restrictions are modest unless macular edema is present.
PDR : Retinal ischemia triggers massive local secretion of Vascular Endothelial Growth Factor (VEGF) , stimulating the rapid proliferation of abnormal, fragile new capillaries across the retinal surface and optic disc ( neovascularization ). These fragile vessels lack mature pericytes and fibrous support.
Hemodynamic Hazards & Contraindicated Activities in PDR
Acute surges in systemic arterial blood pressure or intraocular pressure (IOP) can easily rupture these fragile neovascular vessels, causing massive vitreous hemorrhage or tractional retinal detachment , resulting in permanent visual loss.
Clinical Parameter Proliferative Diabetic Retinopathy (PDR) & Severe NPDR
Absolute Exercise Contraindications - Vigorous-intensity aerobic exercise ( > 75 % HRR > 75\%\text{ HRR} > 75% HRR or RPE > 15 > 15 > 15 ); - Heavy resistance training ( > 70 % – 80 % 1RM > 70\%\text{--}80\%\text{ 1RM} > 70% – 80% 1RM ); - High-intensity isometric straining (e.g., heavy wall sits, sustained planks); - The Valsalva Maneuver (straining against a closed glottis); - Head-down / inverted body postures (decline bench press, yoga inversions, toe touches); - Ballistic, jarring, or high-impact activities (jumping, boxing, plyometrics)
Permitted & Recommended Modalities - Low-to-moderate intensity continuous aerobic exercise (RPE 11–13); - Upright or recumbent cycling, level treadmill walking; - Low-resistance circuit training (12–15 repetitions at 40–50% 1RM) with continuous rhythmic exhalation on exertion
Intraocular Pressure (IOP) Safeguard Straining against a closed glottis raises intrathoracic pressure, impeding ocular venous return and dramatically spiking IOP. Patients must be trained in continuous exhalation during lifting.
Diabetic Nephropathy (Diabetic Kidney Disease - DKD)
Diabetic nephropathy affects approximately 30% to 40% of diabetic patients and represents the leading cause of end-stage renal disease (ESRD).
Clinical Staging & Albuminuria
Screening : Evaluated via a random spot Urinary Albumin-to-Creatinine Ratio (UACR) :
Normal : UACR < 30 mg/g \text{UACR} < 30\text{ mg/g} UACR < 30 mg/g ( < 3 mg/mmol < 3\text{ mg/mmol} < 3 mg/mmol ).
Microalbuminuria (Moderately Increased) : UACR 30 – 300 mg/g \text{UACR } 30\text{--}300\text{ mg/g} UACR 30 – 300 mg/g ( 3 – 30 mg/mmol 3\text{--}30\text{ mg/mmol} 3 – 30 mg/mmol ). Earliest clinical marker of nephropathy and generalized vascular endothelial dysfunction.
Macroalbuminuria (Severely Increased) : UACR > 300 mg/g \text{UACR} > 300\text{ mg/g} UACR > 300 mg/g ( > 30 mg/mmol > 30\text{ mg/mmol} > 30 mg/mmol ).
Exercise Adaptations & Renal Safeguards
Post-Exertional Proteinuria : Strenuous acute exercise causes a transient, benign increase in glomerular permeability, temporarily elevating urinary protein excretion. Extensive clinical trials demonstrate that regular, moderate-intensity exercise does not accelerate long-term renal deterioration and provides substantial cardiovascular benefit.
Blood Pressure Limits : Patients must maintain strict blood pressure control during exercise. Exertional systolic blood pressure surges > 210 – 220 mmHg > 210\text{--}220\text{ mmHg} > 210 – 220 mmHg transmit damaging shear stresses to vulnerable glomeruli and must be avoided. Exercise intensity must be titrated downward if systolic BP approaches these ceilings.
Hydration Vigilance : Ensure adequate oral hydration before, during, and after exercise to prevent volume contraction and prerenal acute kidney injury, while carefully balancing fluid intake in patients with concomitant heart failure or oliguric renal disease.
Comprehensive Complication & Exercise Adaptation Matrix
Diabetic Complication Diagnostic / Assessment Criteria Cardinal Exercise Hazards Mandatory Rehabilitation Adaptations
Cardiovascular Autonomic Neuropathy (CAN) Resting HR > 100 bpm >100\text{ bpm} > 100 bpm , blunted exertional HR, orthostatic BP drop ≥ 20 / 10 mmHg \ge 20/10\text{ mmHg} ≥ 20/10 mmHg Chronotropic incompetence, orthostatic syncope, silent myocardial ischemia Borg RPE 11–14 primary guide; Karvonen invalid; continuous telemetry; prolonged warm-up/cool-down (10–15 min)
Diabetic Peripheral Neuropathy (DPN) Failure to feel 10g Semmes-Weinstein monofilament (LOPS), loss of vibration/Achilles reflex Painless plantar ulceration, skin breakdown, Charcot neuroarthropathy Pre/post visual foot checks ; synthetic wicking socks; cushioned wide shoes; non-impact modalities (recumbent stepper/cycle)
Diabetic Retinopathy (PDR / Severe NPDR) Ophthalmic exam showing neovascularization, microaneurysms, laser scars Vitreous hemorrhage, tractional retinal detachment from IOP/BP spikes No Valsalva ; avoid heavy lifting ( > 70 % 1RM >70\%\text{ 1RM} > 70% 1RM ); avoid head-down/inverted postures; low-mod continuous aerobic only
Diabetic Nephropathy (DKD) Microalbuminuria ( 30 – 300 mg/g 30\text{--}300\text{ mg/g} 30 – 300 mg/g ) or macroalbuminuria ( > 300 mg/g >300\text{ mg/g} > 300 mg/g ) Glomerular barotrauma, volume contraction/prerenal azotemia Cap systolic BP < 210 mmHg <210\text{ mmHg} < 210 mmHg ; maintain careful hydration; adjust renally cleared antidiabetic drugs (metformin/SGLT2i)
Realistic Clinical Scenario: Complex Multi-Complication Adaptation Protocol
Clinical Scenario : A 67-year-old female with a 24-year history of Type 2 diabetes is admitted to Phase II cardiac rehabilitation 5 weeks following CABG × 4 \times 4 × 4 . Her medical history is significant for hypertension, Stage 3a diabetic kidney disease (eGFR 48 mL/min/1.73m 2 48\text{ mL/min/1.73m}^2 48 mL/min/1.73m 2 , UACR 220 mg/g 220\text{ mg/g} 220 mg/g ), proliferative diabetic retinopathy treated with panretinal laser photocoagulation 2 years ago, and distal numbness in bilateral lower extremities.
Baseline Clinical Examination :
Vital Signs : Resting heart rate 104 bpm 104\text{ bpm} 104 bpm (sinus tachycardia on telemetry). Resting supine BP is 136 / 82 mmHg 136/82\text{ mmHg} 136/82 mmHg ; upon standing for 2 minutes, her BP drops to 104 /62 mmHg 104\text{/62 mmHg} 104 /62 mmHg (systolic drop 32 mmHg 32\text{ mmHg} 32 mmHg ) while her heart rate remains unchanged at 104 bpm 104\text{ bpm} 104 bpm . She reports mild postural lightheadedness.
Neurological Exam : Complete inability to perceive the 10g Semmes-Weinstein monofilament at all 4 plantar testing sites bilaterally; absent Achilles tendon reflexes.
Visual Status : Corrected vision 20/40; ophthalmologist clearance document confirms stable inactive PDR with residual peripheral laser scarring, advising against sudden intraocular pressure surges.
Multidisciplinary Exercise Prescription & Safety Plan :
CAN Management : The presence of resting tachycardia, blunted heart rate variability, and severe orthostatic hypotension confirms advanced CAN. Target heart rate calculation is discarded. Exercise intensity is guided strictly by Borg RPE targeting 11 to 13 ("fairly light" to "somewhat hard") . A 12-minute active warm-up and 12-minute cool-down are instituted. Positional transitions (supine to sit to stand) are executed slowly with active ankle pumps.
DPN Management : Given confirmed LOPS, treadmill ambulation is avoided. The patient is prescribed a seated recumbent stepper (NuStep) and recumbent cycle ergometer . The clinician inspects both feet before and after every session. The patient is educated on wearing padded, seamless synthetic socks and inspecting feet at home with a handheld mirror.
Retinopathy & Nephropathy Precautions : Resistance training is restricted to light-intensity elastic bands and bodyweight movements (12–15 repetitions, RPE 11–12), with strict instructions to maintain continuous rhythmic breathing and avoid the Valsalva maneuver. Exercises involving head-down positioning (e.g., decline bench or floor mat inversions) are prohibited. Exertional blood pressure is monitored, ensuring systolic BP remains < 190 mmHg < 190\text{ mmHg} < 190 mmHg , and oral hydration with water is maintained.